Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
5-Amino-1MQ has been discussed in scientific literature involving nicotinamide N-methyltransferase research, also known as NNMT research, metabolic pathway analysis, enzyme activity, molecular signaling, cellular biology, and controlled laboratory models
Keep a personal log of sleep quality, focus, or numbness after each injection to track real-world response and signal the need for possible form adjustments
Injectable cyanocobalamin is needed when oral vitamin supplements are not efficient enough for some dogs
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
